Towards Holistic Toxicology: In-Silico Prediction of Diseases Linked to Multi-chemical Exposures

Bruce Cao^*
*Correspondence: Bruce Cao, Department of Chemistry and Biochemistry, University of Porto, Porto, Portugal, Email:

Introduction

The concept of toxicology has traditionally focused on the study of the harmful effects of individual chemicals on human health. However, in recent years, there has been a growing recognition that humans are rarely exposed to single chemicals in isolation. Instead, they are often exposed to complex mixtures of chemicals, which can act synergistically or antagonistically to influence health outcomes in ways that are not fully understood. This has led to the emerging field of "holistic toxicology," which aims to understand and predict the combined effects of multiple chemical exposures on human health. One of the most promising approaches to achieving this goal is the use of in-silico models, which leverage computational techniques to predict the health impacts of multi-chemical exposures. These models offer a powerful tool for identifying diseases and conditions that may be particularly sensitive to chemical mixtures, enabling more accurate risk assessments and improved public health protection. in-silico toxicology uses computational models to simulate the effects of chemicals on biological systems. These models rely on large datasets that describe the chemical properties of substances, their interactions with biological targets, and the molecular mechanisms through which they exert their effects. By incorporating data from high-throughput screening assays, genomic studies, and other sources, in-silico models can predict how different chemicals may interact within the human body, their potential to cause toxicity, and the diseases or health conditions they may predispose individuals to. This approach has been particularly valuable in addressing the challenges posed by multi-chemical exposures, which cannot easily be studied using traditional experimental methods.

Description

One of the main challenges in understanding multi-chemical exposures is the complexity of the interactions between chemicals. Chemicals can act on the same biological targets or pathways, and their combined effects may be more than just the sum of their individual effects. For example, two chemicals that individually cause mild toxicity may interact to produce more severe health effects when combined. Conversely, some chemicals may counteract each other’s effects, leading to a reduction in toxicity. Understanding these interactions requires sophisticated models that can integrate data from multiple sources and account for the various mechanisms through which chemicals may interact. in-silico models provide a means of testing these interactions in a controlled and reproducible manner, reducing the need for expensive and time-consuming animal experiments. The use of in-silico models to predict diseases linked to multi-chemical exposures has the potential to revolutionize toxicology and public health risk assessment. These models can be used to identify populations that may be particularly vulnerable to chemical mixtures, such as individuals with pre-existing health conditions, genetic predispositions, or other risk factors. By simulating the effects of chemical exposures on these populations, researchers can gain insights into the diseases that may be more likely to develop as a result of exposure to chemical mixtures. This could lead to more targeted and effective public health interventions, such as the development of safety guidelines or regulations that take into account the combined effects of multiple chemicals [1].

In addition to predicting disease outcomes, in-silico models can also be used to identify potential biomarkers of exposure or disease. Biomarkers are measurable indicators of biological processes or conditions, and they can be used to monitor the effects of chemical exposures on human health. By analyzing the molecular changes that occur in response to multi-chemical exposures, in-silico models can help identify biomarkers that could be used in diagnostic tests or to assess the effectiveness of interventions. For example, changes in gene expression, protein levels, or metabolic pathways could be used to track the onset of diseases such as cancer, neurological disorders, or cardiovascular disease, all of which are linked to environmental chemical exposures. One area where in-silico toxicology is making significant strides is in the study of Endocrine-Disrupting Chemicals (EDCs). These chemicals interfere with the body’s endocrine system, which regulates hormones that control many important physiological processes. Exposure to EDCs has been linked to a wide range of diseases, including reproductive disorders, developmental defects, and various forms of cancer. Traditional toxicology approaches have focused primarily on the effects of individual EDCs, but the reality is that people are often exposed to multiple EDCs simultaneously. in-silico models can be used to predict the cumulative effects of these exposures, providing a more accurate picture of the risks associated with endocrine disruption. These models can also help identify new EDCs that may not have been previously recognized, enabling earlier intervention and prevention strategies [2].

Another promising application of in-silico toxicology is in the area of personalized medicine. By combining data on chemical exposures with information about an individual’s genetic makeup, researchers can develop more accurate predictions of how specific chemicals may affect that person’s health. This approach, known as toxicogenomics, has the potential to identify individuals who are genetically predisposed to certain diseases or who may be more susceptible to the harmful effects of chemical exposures. For example, individuals with certain genetic variants may be more likely to develop lung cancer after exposure to tobacco smoke or may have an increased risk of neurological disorders after exposure to pesticides. By incorporating these genetic factors into in-silico models, researchers can refine their predictions and provide more personalized risk assessments. The integration of in-silico toxicology with other emerging technologies, such as artificial intelligence (AI) and machine learning (ML), is further enhancing the predictive power of these models. AI and ML algorithms can process vast amounts of data from diverse sources, including genomics, proteomics, and environmental data, to uncover complex patterns and relationships that might not be immediately apparent. These technologies can also help refine the models by continuously updating them with new data, improving their accuracy over time. By combining in-silico models with AI and ML, researchers can create more sophisticated tools for predicting the health impacts of multi-chemical exposures and identifying new strategies for disease prevention and intervention [3].

Despite the significant advances in in-silico toxicology, there are still several challenges that need to be addressed. One of the main limitations is the availability and quality of data. in-silico models rely heavily on large datasets, but for many chemicals and diseases, the necessary data may be scarce or incomplete. In addition, the interactions between chemicals are often poorly understood, and it can be difficult to account for the full range of biological processes involved. Another challenge is the need for standardized methods for model validation. While in-silico models have shown promise in predicting chemical toxicity, their accuracy and reliability must be rigorously tested in real-world scenarios to ensure that they can be used confidently for regulatory decision-making. There is also a need for more interdisciplinary collaboration between toxicologists, bioinformaticians, chemists, and data scientists. Developing effective in-silico models requires expertise in a range of fields, and fostering collaboration between researchers with different skill sets is essential for overcoming the technical and scientific challenges associated with multi-chemical exposure prediction [4,5].

Conclusion

Use of in-silico models to predict diseases linked to multi-chemical exposures represents a significant advancement in toxicology and public health risk assessment. By integrating data from multiple sources and accounting for the complex interactions between chemicals, these models provide a more accurate and comprehensive understanding of the health risks associated with chemical mixtures. in-silico toxicology holds great promise for identifying vulnerable populations, improving disease prevention strategies, and guiding regulatory decisions. As the field continues to evolve and new technologies are integrated into the models, it is likely that in-silico toxicology will become an essential tool for addressing the challenges posed by environmental exposures in the 21st century.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Jonas, Wayne B. and Elena Rosenbaum. "The case for whole-person integrative care." Med 57 (2021): 677.

Google Scholar, Crossref, Indexed at

2. Thomas, Hayley, Geoffrey Mitchell, Justin Rich and Megan Best. "Definition of whole person care in general practice in the English language literature: A systematic review." BMJ Open 8 (2018): e023758.

Google Scholar, Crossref, Indexed at

3. Langevin, Helene M. "Moving the complementary and integrative health research field toward whole person health." J Altern Complement Med 27 (2021): 623-626.

Google Scholar, Crossref, Indexed at

4. Suvorov, Alexander, Victoria Salemme, Joseph McGaunn and Anthony Poluyanoff, et al. "Unbiased approach for the identification of molecular mechanisms sensitive to chemical exposures." Chemosphere 262 (2021): 128362.

Google Scholar, Crossref, Indexed at

5. Tsatsakis, Aristidis M., Anca Oana Docea and Christina Tsitsimpikou. "New challenges in risk assessment of chemicals when simulating real exposure scenarios; Simultaneous multi-chemicals' low dose exposure." Food Chem Toxicol 96 (2016): 174-176.

Google Scholar, Crossref